Trial Profile
Effects of rifampicin on steady-state plasma pharmacokinetics of efavirenz in African-American and Caucasian volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Apr 2014
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Rifampicin (Primary)
- Indications HIV-1 infections; Tuberculosis
- Focus Pharmacogenomic; Pharmacokinetics
- 02 May 2011 New trial record